FDA — authorised 25 July 1980
- Application: NDA018140
- Marketing authorisation holder: HIKMA
- Local brand name: ATIVAN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Lorazepam (drug) on 25 July 1980
Yes. FDA authorised it on 25 July 1980.
HIKMA holds the US marketing authorisation.